After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the street. Will they ever again get the tag of “ a must have” in one’s portfolio ?. We take a look at 4 MNC pharma companies where analysts have a Buy and Hold recommendation.
J Infratech files IPO papers; eyes Rs 600 cr via fresh issue
J Infratech Ltd has submitted preliminary papers for an initial public offering valued at Rs 600 crore. The IPO includes a fresh issue and an